Onyx retains Nexavar/regorafenib rights on takeover as Bayer settles dispute
13 October 2011
Nancy Faigen
Please Login to read the full article.
13 October 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Positive data leads to early stoppage of Bayer's colorectal cancer drug trial
- Regeneron can open eyes now as Genentech Eylea litigation outcome clears overhang
- J&J to pay $158M to settle Texas Medicaid fraud case
- Onyx delays US filing for carfilzomib multiple myeloma drug, slightly
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
